{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T02:16:40Z","timestamp":1783304200393,"version":"3.54.6"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Bioscience Association of Maine"},{"name":"Northern New England Clinical Oncology Society"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1P20GM144265-01A1"],"award-info":[{"award-number":["1P20GM144265-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004322","name":"Agilent Technologies","doi-asserted-by":"publisher","award":["4845"],"award-info":[{"award-number":["4845"]}],"id":[{"id":"10.13039\/100004322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51149-y","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:15:25Z","timestamp":1778040925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting the D93 cryptic collagen epitope alters integrin \u03b12\u03b21-dependent cellular migration and collagen remodeling in metastatic breast cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Jordan N.","family":"Miner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Emmerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Raite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Vittum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karissa","family":"Tilbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"51149_CR1","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.3390\/cancers15082204","volume":"15","author":"MA Subhan","year":"2023","unstructured":"Subhan, M. A. et al. Recent advances with precision medicine treatment for breast cancer including triple-negative sub-type. Cancers 15, 2204 (2023).","journal-title":"Cancers"},{"key":"51149_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1405491","volume":"14","author":"N Xiong","year":"2024","unstructured":"Xiong, N., Wu, H. & Yu, Z. Advancements and challenges in triple-negative breast cancer: A comprehensive review of therapeutic and diagnostic strategies. Front. Oncol. 14, 1405491 (2024).","journal-title":"Front. Oncol."},{"key":"51149_CR3","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1016\/S0305-7372(10)70025-6","volume":"36","author":"M De Laurentiis","year":"2010","unstructured":"De Laurentiis, M. et al. Treatment of triple negative breast cancer (TNBC): current options and future perspectives. Cancer Treat. Rev. 36, S80\u2013S86 (2010).","journal-title":"Cancer Treat. Rev."},{"key":"51149_CR4","doi-asserted-by":"publisher","first-page":"9005","DOI":"10.1002\/jcp.29752","volume":"235","author":"X Han","year":"2020","unstructured":"Han, X., Caron, J. M. & Brooks, P. C. Cryptic collagen elements as signaling hubs in the regulation of tumor growth and metastasis. J. Cell. Physiol. 235, 9005\u20139020 (2020).","journal-title":"J. Cell. Physiol."},{"key":"51149_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s40364-025-00757-3","volume":"13","author":"JJ Lee","year":"2025","unstructured":"Lee, J. J., Ng, K. Y. & Bakhtiar, A. Extracellular matrix: Unlocking new avenues in cancer treatment. Biomark. Res. 13, 78 (2025).","journal-title":"Biomark. Res."},{"key":"51149_CR6","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1200\/JCO.20.00590","volume":"38","author":"E Van Cutsem","year":"2020","unstructured":"Van Cutsem, E. et al. Randomized phase III trial of pegvorhyaluronidase alfa with nab-paclitaxel plus gemcitabine for patients with hyaluronan-high metastatic pancreatic adenocarcinoma. J. Clin. Oncol. 38, 3185\u20133194 (2020).","journal-title":"J. Clin. Oncol."},{"key":"51149_CR7","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/hep.31236","volume":"72","author":"W Chen","year":"2020","unstructured":"Chen, W. et al. Lysyl oxidase (LOX) family members: Rationale and their potential as therapeutic targets for liver fibrosis. Hepatology 72, 729\u2013741 (2020).","journal-title":"Hepatology"},{"key":"51149_CR8","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.trecan.2025.05.003","volume":"11","author":"JL Chitty","year":"2025","unstructured":"Chitty, J. L. & Cox, T. R. The extracellular matrix in cancer: From understanding to targeting. Trends Cancer 11, 839\u2013849 (2025).","journal-title":"Trends Cancer"},{"key":"51149_CR9","doi-asserted-by":"publisher","first-page":"650453","DOI":"10.3389\/fonc.2021.650453","volume":"11","author":"Y Zhao","year":"2021","unstructured":"Zhao, Y. et al. Extracellular matrix: Emerging roles and potential therapeutic targets for breast cancer. Front. Oncol. 11, 650453 (2021).","journal-title":"Front. Oncol."},{"key":"51149_CR10","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1158\/1535-7163.MCT-17-0646","volume":"17","author":"A Winer","year":"2018","unstructured":"Winer, A., Adams, S. & Mignatti, P. Matrix metalloproteinase inhibitors in cancer therapy: Turning past failures into future successes. Mol. Cancer Ther. 17, 1147\u20131155 (2018).","journal-title":"Mol. Cancer Ther."},{"key":"51149_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.actbio.2023.01.025","volume":"163","author":"SM Siadat","year":"2023","unstructured":"Siadat, S. M. & Ruberti, J. W. Mechanochemistry of collagen. Acta Biomater. 163, 50\u201362 (2023).","journal-title":"Acta Biomater."},{"key":"51149_CR12","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1016\/j.ajpath.2018.06.017","volume":"188","author":"JM Caron","year":"2018","unstructured":"Caron, J. M., Han, X., Contois, L., Vary, C. P. H. & Brooks, P. C. The HU177 collagen epitope controls melanoma cell migration and experimental metastasis by a CDK5\/YAP-dependent mechanism. Am. J. Pathol. 188, 2356\u20132368 (2018).","journal-title":"Am. J. Pathol."},{"key":"51149_CR13","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/j.ajpath.2016.01.015","volume":"186","author":"JM Caron","year":"2016","unstructured":"Caron, J. M. et al. Inhibition of ovarian tumor growth by targeting the HU177 cryptic collagen epitope. Am. J. Pathol. 186, 1649\u20131661 (2016).","journal-title":"Am. J. Pathol."},{"key":"51149_CR14","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1158\/1078-0432.CCR-06-2342","volume":"13","author":"A Cretu","year":"2007","unstructured":"Cretu, A. et al. Disruption of endothelial cell interactions with the novel HU177 cryptic collagen epitope inhibits angiogenesis. Clin. Cancer Res. 13, 3068\u20133078 (2007).","journal-title":"Clin. Cancer Res."},{"key":"51149_CR15","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1016\/j.molimm.2007.03.027","volume":"44","author":"B Freimark","year":"2007","unstructured":"Freimark, B. et al. Targeting of humanized antibody D93 to sites of angiogenesis and tumor growth by binding to multiple epitopes on denatured collagens. Mol. Immunol. 44, 3741\u20133750 (2007).","journal-title":"Mol. Immunol."},{"key":"51149_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","volume":"141","author":"K Kessenbrock","year":"2010","unstructured":"Kessenbrock, K., Plaks, V. & Werb, Z. Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell 141, 52\u201367 (2010).","journal-title":"Cell"},{"key":"51149_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010146","volume":"23","author":"S Niland","year":"2022","unstructured":"Niland, S., Riscanevo, A. X. & Eble, J. A. Matrix metalloproteinases shape the tumor microenvironment in cancer progression. Int. J. Mol. Sci. 23, 146 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"51149_CR18","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.matbio.2015.01.005","volume":"44\u201346","author":"SR Van Doren","year":"2015","unstructured":"Van Doren, S. R. Matrix metalloproteinase interactions with collagen and elastin. Matrix Biol. 44\u201346, 224\u2013231 (2015).","journal-title":"Matrix Biol."},{"key":"51149_CR19","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/S0002-9440(10)61222-9","volume":"167","author":"PJ Gagne","year":"2005","unstructured":"Gagne, P. J. et al. Temporal exposure of cryptic collagen epitopes within ischemic muscle during hindlimb reperfusion. Am. J. Pathol. 167, 1349\u20131359 (2005).","journal-title":"Am. J. Pathol."},{"key":"51149_CR20","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/prca.201300085","volume":"8","author":"M Fonovi\u0107","year":"2014","unstructured":"Fonovi\u0107, M. & Turk, B. Cysteine cathepsins and their potential in clinical therapy and biomarker discovery. Proteomics. Clin. Appl. 8, 416\u2013426 (2014).","journal-title":"Proteomics. Clin. Appl."},{"key":"51149_CR21","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1042\/bj3310727","volume":"331","author":"W Kafienah","year":"1998","unstructured":"Kafienah, W., Br\u00f6mme, D., Buttle, D. J., Croucher, L. J. & Hollander, A. P. Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem. J. 331, 727\u2013732 (1998).","journal-title":"Biochem. J."},{"key":"51149_CR22","doi-asserted-by":"publisher","first-page":"e12337","DOI":"10.1371\/journal.pone.0012337","volume":"5","author":"BP Flynn","year":"2010","unstructured":"Flynn, B. P. et al. Mechanical strain stabilizes reconstituted collagen fibrils against enzymatic degradation by mammalian collagenase matrix metalloproteinase 8 (MMP-8). PLoS One 5, e12337 (2010).","journal-title":"PLoS One"},{"key":"51149_CR23","doi-asserted-by":"publisher","first-page":"13259","DOI":"10.1021\/ja212170b","volume":"134","author":"AS Adhikari","year":"2012","unstructured":"Adhikari, A. S., Glassey, E. & Dunn, A. R. Conformational dynamics accompanying the proteolytic degradation of trimeric collagen I by collagenases. J. Am. Chem. Soc. 134, 13259\u201313265 (2012).","journal-title":"J. Am. Chem. Soc."},{"key":"51149_CR24","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1200\/jco.2010.28.15_suppl.3038","volume":"28","author":"F Robert","year":"2010","unstructured":"Robert, F. et al. Final results from a phase I study of TRC093 (humanized anti-cleaved collagen antibody) in patients with solid cancer. J. Clin. Oncol. 28, 3038 (2010).","journal-title":"J. Clin. Oncol."},{"key":"51149_CR25","doi-asserted-by":"publisher","first-page":"782766","DOI":"10.3389\/fonc.2021.782766","volume":"11","author":"AMK Law","year":"2021","unstructured":"Law, A. M. K. et al. Advancements in 3D cell culture systems for personalizing anti-cancer therapies. Front. Oncol. 11, 782766 (2021).","journal-title":"Front. Oncol."},{"key":"51149_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/cpcb.105","volume":"87","author":"SS Nazari","year":"2020","unstructured":"Nazari, S. S. Generation of 3D tumor spheroids with encapsulating basement membranes for invasion studies. Curr. Protoc. Cell Biol. 87, e105 (2020).","journal-title":"Curr. Protoc. Cell Biol."},{"key":"51149_CR27","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1242\/jcs.188672","volume":"129","author":"C Zeltz","year":"2016","unstructured":"Zeltz, C. & Gullberg, D. The integrin\u2013collagen connection \u2013 A glue for tissue repair?. J. Cell Sci. 129, 653\u2013664 (2016).","journal-title":"J. Cell Sci."},{"key":"51149_CR28","doi-asserted-by":"publisher","first-page":"876","DOI":"10.3390\/polym14050876","volume":"14","author":"J Elango","year":"2022","unstructured":"Elango, J. et al. The molecular interaction of collagen with cell receptors for biological function. Polymers 14, 876 (2022).","journal-title":"Polymers"},{"key":"51149_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2748","volume":"10","author":"JS Desgrosellier","year":"2010","unstructured":"Desgrosellier, J. S. & Cheresh, D. A. Integrins in cancer: Biological implications and therapeutic opportunities. Nat. Rev. Cancer 10, 9\u201322 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"51149_CR30","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3390\/cells10030662","volume":"10","author":"M Musiime","year":"2021","unstructured":"Musiime, M. et al. Collagen assembly at the cell surface: dogmas revisited. Cells 10, 662 (2021).","journal-title":"Cells"},{"key":"51149_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01488","volume":"10","author":"I Bourgot","year":"2020","unstructured":"Bourgot, I., Primac, I., Louis, T., No\u00ebl, A. & Maquoi, E. Reciprocal interplay between fibrillar collagens and collagen-binding integrins: Implications in cancer progression and metastasis. Front. Oncol. 10, 1488 (2020).","journal-title":"Front. Oncol."},{"key":"51149_CR32","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1741-7015-4-38","volume":"4","author":"PP Provenzano","year":"2006","unstructured":"Provenzano, P. P. et al. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. 4, 38 (2006).","journal-title":"BMC Med."},{"key":"51149_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s40170-020-00221-w","volume":"8","author":"EA Brett","year":"2020","unstructured":"Brett, E. A., Sauter, M. A., Machens, H.-G. & Duscher, D. Tumor-associated collagen signatures: Pushing tumor boundaries. Cancer Metab. 8, 14 (2020).","journal-title":"Cancer Metab."},{"key":"51149_CR34","first-page":"21","volume":"7","author":"K Tilbury","year":"2015","unstructured":"Tilbury, K. & Campagnola, P. J. Applications of second-harmonic generation imaging microscopy in ovarian and breast cancer. Perspect. Med. Chem. 7, 21\u201332 (2015).","journal-title":"Perspect. Med. Chem."},{"key":"51149_CR35","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.optcom.2007.10.040","volume":"281","author":"R LaComb","year":"2008","unstructured":"LaComb, R., Nadiarnykh, O., Townsend, S. S. & Campagnola, P. J. Phase matching considerations in second harmonic generation from tissues: Effects on emission directionality, conversion efficiency and observed morphology. Opt. Commun. 281, 1823\u20131832 (2008).","journal-title":"Opt. Commun."},{"key":"51149_CR36","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12885-017-3090-2","volume":"17","author":"KB Tilbury","year":"2017","unstructured":"Tilbury, K. B. et al. Stromal alterations in ovarian cancers via wavelength dependent second harmonic generation microscopy and optical scattering. BMC Cancer 17, 102 (2017).","journal-title":"BMC Cancer"},{"key":"51149_CR37","doi-asserted-by":"publisher","DOI":"10.1117\/1.JBO.18.3.031106","volume":"18","author":"K Burke","year":"2012","unstructured":"Burke, K., Tang, P. & Brown, E. B. Second harmonic generation reveals matrix alterations during breast tumor progression. J. Biomed. Opt. 18, 031106 (2012).","journal-title":"J. Biomed. Opt."},{"key":"51149_CR38","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1186\/s12885-020-07713-4","volume":"20","author":"DE Desa","year":"2020","unstructured":"Desa, D. E. et al. Intratumoral heterogeneity of second-harmonic generation scattering from tumor collagen and its effects on metastatic risk prediction. BMC Cancer 20, 1217 (2020).","journal-title":"BMC Cancer"},{"key":"51149_CR39","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0030-4018(01)01403-1","volume":"196","author":"J Mertz","year":"2001","unstructured":"Mertz, J. & Moreaux, L. Second-harmonic generation by focused excitation of inhomogeneously distributed scatterers. Opt. Commun. 196, 325\u2013330 (2001).","journal-title":"Opt. Commun."},{"key":"51149_CR40","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1364\/OE.16.001846","volume":"16","author":"X Han","year":"2008","unstructured":"Han, X., Burke, R. M., Zettel, M. L., Tang, P. & Brown, E. B. Second harmonic properties of tumor collagen: Determining the structural relationship between reactive stroma and healthy stroma. Opt. Express 16, 1846\u20131859 (2008).","journal-title":"Opt. Express"},{"key":"51149_CR41","doi-asserted-by":"publisher","DOI":"10.1117\/1.JBO.20.5.051024","volume":"20","author":"KA Burke","year":"2015","unstructured":"Burke, K. A. et al. Second-harmonic generation scattering directionality predicts tumor cell motility in collagen gels. J. Biomed. Opt. 20, 051024 (2015).","journal-title":"J. Biomed. Opt."},{"key":"51149_CR42","first-page":"1371","volume":"29","author":"F Pernasetti","year":"2006","unstructured":"Pernasetti, F. et al. Novel anti-denatured collagen humanized antibody D93 inhibits angiogenesis and tumor growth: An extracellular matrix-based therapeutic approach. Int. J. Oncol. 29, 1371\u20131379 (2006).","journal-title":"Int. J. Oncol."},{"key":"51149_CR43","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/jnci\/92.14.1185a","volume":"92","author":"FR Miller","year":"2000","unstructured":"Miller, F. R., Santner, S. J., Tait, L. & Dawson, P. J. MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. JNCI J. Natl. Cancer Inst. 92, 1185\u20131186 (2000).","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"51149_CR44","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1023\/A:1006461422273","volume":"65","author":"SJ Santner","year":"2001","unstructured":"Santner, S. J. et al. Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res. Treat. 65, 101\u2013110 (2001).","journal-title":"Breast Cancer Res. Treat."},{"key":"51149_CR45","first-page":"31","volume":"4","author":"JY So","year":"2012","unstructured":"So, J. Y., Lee, H. J., Kramata, P., Minden, A. & Suh, N. Differential expression of key signaling proteins in MCF10 cell lines, a human breast cancer progression model. Mol. Cell. Pharmacol. 4, 31\u201340 (2012).","journal-title":"Mol. Cell. Pharmacol."},{"key":"51149_CR46","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/j.bpj.2009.07.035","volume":"97","author":"Y Yang","year":"2009","unstructured":"Yang, Y., Leone, L. M. & Kaufman, L. J. Elastic moduli of collagen gels can be predicted from two-dimensional confocal microscopy. Biophys. J. 97, 2051\u20132060 (2009).","journal-title":"Biophys. J."},{"key":"51149_CR47","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ccr.2005.08.010","volume":"8","author":"MJ Paszek","year":"2005","unstructured":"Paszek, M. J. et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 8, 241\u2013254 (2005).","journal-title":"Cancer Cell"},{"key":"51149_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1284926","volume":"13","author":"R Xu","year":"2023","unstructured":"Xu, R., Yin, P., Wei, J. & Ding, Q. The role of matrix stiffness in breast cancer progression: A review. Front. Oncol. 13, 1284926 (2023).","journal-title":"Front. Oncol."},{"key":"51149_CR49","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-94-017-9153-3_3","volume-title":"I Domain Integrins","author":"A Madamanchi","year":"2014","unstructured":"Madamanchi, A., Santoro, S. A. & Zutter, M. M. \u03b12\u03b21 integrin. In I Domain Integrins 41\u201360 (Springer, 2014)."},{"key":"51149_CR50","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1172\/JCI42328","volume":"121","author":"NE Ramirez","year":"2011","unstructured":"Ramirez, N. E. et al. The \u03b12\u03b21 integrin is a metastasis suppressor in mouse models and human cancer. J. Clin. Invest. 121, 226\u2013237 (2011).","journal-title":"J. Clin. Invest."},{"key":"51149_CR51","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10549-005-9089-4","volume":"97","author":"U Langsenlehner","year":"2006","unstructured":"Langsenlehner, U. et al. Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk. Breast Cancer Res. Treat. 97, 67\u201372 (2006).","journal-title":"Breast Cancer Res. Treat."},{"key":"51149_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137226","volume":"25","author":"L Herrera-Quintana","year":"2024","unstructured":"Herrera-Quintana, L., V\u00e1zquez-Lorente, H. & Plaza-Diaz, J. Breast cancer: Extracellular matrix and microbiome interactions. Int. J. Mol. Sci. 25, 7226 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"51149_CR53","doi-asserted-by":"crossref","unstructured":"Campagnola, P. J. & Shelton, E. Computation analyses of collagen fibril\/fiber structure in ovarian cancer. in Multiphoton Microscopy in the Biomedical Sciences XXV vol. PC133240T (Proc. SPIE PC13324, 2025).","DOI":"10.1117\/12.3042130"},{"key":"51149_CR54","doi-asserted-by":"publisher","DOI":"10.1117\/1.JBO.26.6.065002","volume":"26","author":"K Tilbury","year":"2021","unstructured":"Tilbury, K., Han, X., Brooks, P. C. & Khalil, A. Multiscale anisotropy analysis of second-harmonic generation collagen imaging of mouse skin. J. Biomed. Opt. 26, 065002 (2021).","journal-title":"J. Biomed. Opt."},{"key":"51149_CR55","doi-asserted-by":"publisher","first-page":"991850","DOI":"10.3389\/fonc.2022.991850","volume":"12","author":"J Hamilton","year":"2022","unstructured":"Hamilton, J. et al. Multiscale anisotropy analysis of second-harmonic generation collagen imaging of human pancreatic cancer. Front. Oncol. 12, 991850 (2022).","journal-title":"Front. Oncol."},{"key":"51149_CR56","doi-asserted-by":"publisher","first-page":"016007","DOI":"10.1117\/1.JBO.19.1.016007","volume":"19","author":"JS Bredfeldt","year":"2014","unstructured":"Bredfeldt, J. S. et al. Computational segmentation of collagen fibers from second-harmonic generation images of breast cancer. J. Biomed. Opt. 19, 016007 (2014).","journal-title":"J. Biomed. Opt."},{"key":"51149_CR57","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10555-006-7887-8","volume":"25","author":"S Jodele","year":"2006","unstructured":"Jodele, S., Blavier, L., Yoon, J. M. & DeClerck, Y. A. Modifying the soil to affect the seed: Role of stromal-derived matrix metalloproteinases in cancer progression. Cancer Metastasis Rev. 25, 35\u201343 (2006).","journal-title":"Cancer Metastasis Rev."},{"key":"51149_CR58","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","volume":"139","author":"KR Levental","year":"2009","unstructured":"Levental, K. R. et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139, 891\u2013906 (2009).","journal-title":"Cell"},{"key":"51149_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/jir.2014.0026","volume":"35","author":"M Esquivel-Vel\u00e1zquez","year":"2015","unstructured":"Esquivel-Vel\u00e1zquez, M. et al. The role of cytokines in breast cancer development and progression. J. Interferon Cytokine Res. 35, 1\u201316 (2015).","journal-title":"J. Interferon Cytokine Res."},{"key":"51149_CR60","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0945-053X(02)00037-9","volume":"21","author":"JD Whittard","year":"2002","unstructured":"Whittard, J. D. et al. E-cadherin is a ligand for integrin \u03b12\u03b21. Matrix Biol. 21, 525\u2013532 (2002).","journal-title":"Matrix Biol."},{"key":"51149_CR61","doi-asserted-by":"publisher","first-page":"7624","DOI":"10.3390\/ijms21207624","volume":"21","author":"I Kaszak","year":"2020","unstructured":"Kaszak, I. et al. Role of cadherins in cancer - a review. Int. J. Mol. Sci. 21, 7624 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"51149_CR62","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/1476-4598-9-179","volume":"9","author":"YL Chao","year":"2010","unstructured":"Chao, Y. L., Shepard, C. R. & Wells, A. Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Mol. Cancer. 9, 179 (2010).","journal-title":"Mol. Cancer."},{"key":"51149_CR63","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1242\/jcs.100115","volume":"126","author":"M Canel","year":"2013","unstructured":"Canel, M., Serrels, A., Frame, M. C. & Brunton, V. G. E-cadherin\u2013integrin crosstalk in cancer invasion and metastasis. J. Cell Sci. 126, 393\u2013401 (2013).","journal-title":"J. Cell Sci."},{"key":"51149_CR64","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/978-1-60761-984-0_12","volume-title":"3D Cell Culture: Methods and Protocols","author":"JB Phillips","year":"2011","unstructured":"Phillips, J. B. & Brown, R. Micro-structured materials and mechanical cues in 3D collagen gels. In 3D Cell Culture: Methods and Protocols (ed. Haycock, J. W.) 183\u2013196 (Humana Press, 2011)."},{"key":"51149_CR65","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1177\/0885328215597818","volume":"30","author":"C O\u2019Rourke","year":"2015","unstructured":"O\u2019Rourke, C., Drake, R. A., Cameron, G. W., Jane Loughlin, A. & Phillips, J. B. Optimising contraction and alignment of cellular collagen hydrogels to achieve reliable and consistent engineered anisotropic tissue. J. Biomater. Appl. 30, 599\u2013607 (2015).","journal-title":"J. Biomater. Appl."},{"key":"51149_CR66","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41578-020-0199-8","volume":"5","author":"EA Aisenbrey","year":"2020","unstructured":"Aisenbrey, E. A. & Murphy, W. L. Synthetic alternatives to Matrigel. Nat. Rev. Mater. 5, 539\u2013551 (2020).","journal-title":"Nat. Rev. Mater."},{"key":"51149_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-30403-7","volume":"13","author":"K Karrobi","year":"2023","unstructured":"Karrobi, K. et al. Fluorescence lifetime imaging microscopy (FLIM) reveals spatial-metabolic changes in 3D breast cancer spheroids. Sci. Rep. 13, 3624 (2023).","journal-title":"Sci. Rep."},{"key":"51149_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-01853-8","volume":"21","author":"SJ Han","year":"2021","unstructured":"Han, S. J., Kwon, S. & Kim, K. S. Challenges of applying multicellular tumor spheroids in preclinical phase. Cancer Cell Int. 21, 152 (2021).","journal-title":"Cancer Cell Int."},{"key":"51149_CR69","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nprot.2008.226","volume":"4","author":"J Friedrich","year":"2009","unstructured":"Friedrich, J., Seidel, C., Ebner, R. & Kunz-Schughart, L. A. Spheroid-based drug screen: Considerations and practical approach. Nat. Protoc. 4, 309\u2013324 (2009).","journal-title":"Nat. Protoc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51149-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51149-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51149-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T02:05:19Z","timestamp":1783303519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51149-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51149"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51149-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8406370\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20737"}}